Request for Information - Radiopharmaceuticals for Naval Medical Center Portsmouth, VA, Naval Medical Center Camp Lejeune, Nc, and Naval Health Clinic Jacksonville, Fl

Defense Health Agency · United States government procurement

Closed April 26, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

This is a Request for Information (RFI) to identify potential sources possessing the capabilities described herein and ascertain whether the required supplies are commercial in nature. This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offer will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained.

NOTE: Currently no solicitation exists. Therefore, please do not request a copy of the solicitation. NO PHONE CALLS WILL BE ACCEPTED. It is the responsibility of any potential Offeror to monitor this site for the release of any solicitation.

RFI Title: Radiopharmaceuticals for the Defense Health Agency (DHA) Multiple Medical Treatment Facilities (MTF).
LOCATIONS: Naval Medical Center Portsmouth, Portsmouth, VA 23708, Naval Medical Center Camp Lejeune, Jacksonville, NC and Naval Health Clinic Jacksonville, FL.
BACKGROUND: Three (3) Medical Treatment Facility (MTF) Radiology Departments require one new Indefinite Delivery, Indefinite Quantity contract for the delivery of radiopharmaceuticals, as current contracts expire on September 30, 2026. The radiopharmaceuticals need to be delivered on an as needed basis to each requiring Radiology Department.
DESCRIPTION: NAICS 325412 Pharmaceutical Preparation Manufacturing, PSC 6505 Drugs...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyDefense Health Agency
CountryUnited States
CategoryPharmaceuticals
NAICS325412
PSC6505
PublishedApril 11, 2026
Procurement stageActive solicitation
ClosedApril 26, 2026
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 10, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Browse Similar Open Opportunities in United States

PPVG GEN V Award
National Retardant
PPVG GEN V AWARD SPE2DX25D8000
Febuxostat National Contract
Ziprasidone Capsules
Hydrocodone Acetaminophen
Olanzapine SPE2D2-25-D-0011 Award
Olopatadine HCL 0.1% Ophthalmic Solution

See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Pharmaceuticals intelligence report in your inbox

A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.